Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters

Abstract

Masked hypertension is defined as low clinic and elevated out-of-clinic pressure (blood pressure, BP) assessed either by patients at home or by ambulatory monitoring. This study compared the cardiovascular status and psychometric characteristics of masked, white coat and sustained hypertensives. Three groups of consecutive subjects with masked (n=100, age 59±11 years), white coat (n=100, 60±10 years) and sustained hypertension (n=100, 60±11 years) diagnosed by ambulatory BP monitoring were compared. Masked hypertensives had higher educational level, exercised more frequently, received fewer drugs and sensed more responsibilities at work than at home. Their left ventricular hypertrophy indexes fall in-between those with white coat and sustained, the latter having the highest values. The estimated total cardiovascular risk was intermediate between white coat and sustained, whereas their cardiovascular morbidity and renal disease was higher than that of white coat and similar to sustained. Psychological profile analysis showed lower score for type-A personality and their mood behaviour in the hypomania–euthymia range compared with white coat and sustained hypertensives. The cardiovascular risk of masked hypertensives is higher than that of white coat and similar to sustained. Masked hypertensives have higher educational level, better physical training and different personality/mood pattern than white coat and sustained.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al., European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821–848.

    Article  CAS  Google Scholar 

  2. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R . Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47: 846–853.

    Article  CAS  Google Scholar 

  3. Pickering TG, Davidson K, Gerin W, Schwartz JE . Masked hypertension. Hypertension 2002; 40: 795–796.

    Article  CAS  Google Scholar 

  4. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population based observation in Ohasama, Japan. J Hypertens 1998; 16: 971–975.

    Article  CAS  Google Scholar 

  5. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home blood pressure: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385–1392.

    Article  CAS  Google Scholar 

  6. Wing L, Brown M, Beilin L, Ryan P, Reid C, Investigators on behalf of the ANBP2 Management Committee. Reverse white coat hypertension in older hypertensives. J Hypertens 2002; 20: 639–644.

    Article  CAS  Google Scholar 

  7. Bobrie G, Genes N, Vaur L, Clerson P, Vaisse B, Mallion JM et al. Is ‘isolated home’ hypertension as opposed to ‘isolated office’ hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001; 161: 2205–2211.

    Article  CAS  Google Scholar 

  8. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B et al. Cardiovascular prognosis of ‘masked hypertension’ detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342–1349.

    Article  CAS  Google Scholar 

  9. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin P-F . Masked hypertension: a systematic review. J Hypertens 2008; 26: 1715–1725.

    Article  CAS  Google Scholar 

  10. Lui JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB . Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564–572.

    Google Scholar 

  11. Björklund K, Lind L, Zethelius B, Andren B, Lithell H . Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107: 1297–1302.

    Article  Google Scholar 

  12. Parati G, Stergiou GS, Asmar R, Beilo G, Leeuw P, Imai Y, et al., On behalf of the ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26: 1505–1530.

    Article  CAS  Google Scholar 

  13. Pickering TG, Eguchi K, Kario K . Masked hypertension: a review. Hypertens Res 2007; 30: 479–488.

    Article  Google Scholar 

  14. Selenta C, Hogan BE, Linden W . How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med 2000; 9: 533–540.

    Article  CAS  Google Scholar 

  15. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG . Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens 2005; 18: 772–778.

    Article  Google Scholar 

  16. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

    Article  Google Scholar 

  17. Dabl® Educational Trust. Devices for blood pressure measurement. Available at: http://www.dableducational.org. December 2008.

  18. Kawachi I, Sparrow D, Kubzansky LD, Spiro A, Vokonas PS, Weiss ST . Prospective study of a self-report type A scale and risk of coronary heart disease. Test of the MMPI-2 Type A Scale. Circulation 1998; 98: 405–412.

    Article  CAS  Google Scholar 

  19. Von Zerssen D, Koeller DM, Ray ER . Die Befindlichkeits-Skala (B-S) ein einfaches instrument zur Objektivierung von Befindlichkeitsstörungen insbesondere im Rahmen von Längsschnittsuntersuchungen. Arzneim-Forsch. Drug Res 1970; 20: 915–918.

    CAS  Google Scholar 

  20. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B . MMPI-2: Minnesota Multiphasic Personality Inventory-2. Manual for Administration and Scoring. University of Minnesota Press: Minneapolis, MN, 1989.

  21. Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56–62.

    Article  CAS  Google Scholar 

  22. Cockcroft DW, Gault MH . Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.

    Article  CAS  Google Scholar 

  23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.

    Article  CAS  Google Scholar 

  24. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, Backer GD, et al., On behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

    Article  CAS  Google Scholar 

  25. Vyssoulis G, Karpanou E, Adamopoulos D, Kyvelou S-M, Gymnopoulou E, Cokkinos D et al. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension. Blood Press Monitoring 2008; 13: 251–256.

    Article  Google Scholar 

  26. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S et al. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006; 19: 880–886.

    Article  Google Scholar 

  27. Pickering TG . Morning hypertension. J Clin Hypertens 2007; 9: 224–228.

    Article  Google Scholar 

  28. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M . In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger men. Am J Hypertens 2005; 18: 897–903.

    Google Scholar 

  29. Fagard R, Cornellissen V . Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25: 2193–2198.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Parts of this work have been presented at the 17th European Society of Hypertension Meeting, Milan 2007 and the 1st World Congress on Controversies in Obesity, Diabetes and Hypertension, Berlin 2006.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D E Papadogiannis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konstantopoulou, A., Konstantopoulou, P., Papargyriou, I. et al. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters. J Hum Hypertens 24, 151–157 (2010). https://doi.org/10.1038/jhh.2009.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2009.55

Keywords

This article is cited by

Search

Quick links